LoRusso, Patricia M <br/><br/>
Pilot Trial of Selecting Molecularly Guided Therapy for Patients with Non-V600 BRAF-Mutant Metastatic Melanoma: Experience of the SU2C/MRA Melanoma Dream Team.  [electronic resource] 

 -  Molecular cancer therapeutics  Aug 2015 
 - 1962-71 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1538-8514 
<br/><br/><label>Standard No.: </label>10.1158/1535-7163.MCT-15-0153  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antibodies, Monoclonal--administration & dosage<br/>Antineoplastic Agents--administration & dosage<br/>Female<br/>Humans<br/>Male<br/>Melanoma--diagnosis<br/>Middle Aged<br/>Molecular Targeted Therapy<br/>Mutation<br/>Phenotype<br/>Pilot Projects<br/>Proto-Oncogene Proteins B-raf--genetics<br/>Treatment Outcome